Synaptoprotection in Perinatal Asphyxia: An Experimental Approach

Perinatal asphyxia (PA) is an obstetric complication occurring when oxygen supply to the newborn is temporally interrupted. This health problem is associated with high morbimortality in term and preterm neonates. It severely affects brain structure and function, involving cortical, hippocampal, and striatal loss of neurons. Nearly 25% of PA survivor newborns develop several neurodevelopmental disabilities. Behavioural alterations, as well as morphological and biochemical pathways involved in PA pathophysiology, have been studied using an animal model that resembles intrauterine asphyxia. Experimental evidence shows that PA induces synaptic derangement. Then, synaptic dysfunction embodies a putative target for neuroprotective strategies. Over the last years, therapeutic hypothermia, the only treatment available, has shown positive results in the clinic. Several pharmacological agents are being tested in experimental or clinical trial studies to prevent synaptopathy. Preservation of the synaptic structure and function, v. g., ‘synaptoprotection’, makes up a promising challenge for reducing incidental neurodevelopmental disorders associated with PA. Accordingly, here we summarize and review the findings obtained from the referred experimental model and propose a renewed overview in the field.